Elicio Therapeutics, Inc.

NASDAQ:ELTX

Biotechnology

Healthcare
$2.70 -18.90%

-$0.89 today

Market cap
$51.48M
Beta
1.14
P/E (TTM)
-1.7
EPS (TTM)
-$2.21
52W Low $2.66High $16.00

Volume 0.41M

Average 0.34M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$37.71M

FY 2025 · Annual

Net Income

-$39.57M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue28.31M0000
Cost of Revenue1.23M1.06M1.17M1.18M1.13M
Gross Profit27.08M(1.06M)(1.17M)(1.18M)(1.13M)
Gross Margin95.6%————
Research & Development48.61M17.05M22.68M33.66M24.9M
Selling, General & Admin17.78M5.63M11.9M11.33M12.81M
Operating Expenses66.39M22.68M34.58M43.81M36.59M
Depreciation & Amortization801K1.06M1.17M1.18M1.13M
EBITDA(51.93M)(23.55M)(32.97M)(50.27M)(37.31M)
EBITDA Margin-183.4%————
Operating Income(39.31M)(23.73M)(35.75M)(44.99M)(37.71M)
Operating Margin-138.8%————
Interest Income3.39K64.83K373K777K776K
Interest Expense876.44K3.6M1.06M455K1.13M
Other Income / Expenses(15.27M)(4.48M)550K(6.91M)(1.86M)
Income Before Tax(54.57M)(28.21M)(35.2M)(51.9M)(39.57M)
Pre-Tax Margin-192.8%————
Income Tax Expense00000
Net Income(26.4M)(28.21M)(35.2M)(51.9M)(39.57M)
Net Margin-93.2%————
EPS (Basic)(19.32)(9.10)(6.96)(4.25)(2.58)
EPS (Diluted)(19.32)(9.10)(6.96)(4.25)(2.58)
Weighted Avg Shares3.2M3.1M5.06M12.2M15.31M
Weighted Avg Shares (Diluted)3.2M3.1M5.06M12.2M15.31M

ELTX Earnings Waterfall · TTM

NASDAQ:ELTX · Revenue to Net Income

Key Ratios

EPS$-2.36
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-3.9
P/S Ratio0.0

Analysis

$0 of revenue converted into -$40.2M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-2.36, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportAug 13, 2026
8-KCurrent reportAug 13, 2026
4Statement of changes in beneficial ownershipJul 17, 2026
4Statement of changes in beneficial ownershipJul 17, 2026
4Statement of changes in beneficial ownershipJul 17, 2026

How much revenue does ELTX generate?

Elicio Therapeutics, Inc. (ELTX) reported $0.00 of revenue in fiscal 2025.

Is ELTX profitable?

Elicio Therapeutics, Inc. (ELTX) reported -$39.57M of net income.